• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® FSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® FSH Back to Search Results
Catalog Number 30407
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of invalid calibration and s1 results associated with vidas® fsh reference (30407).The customer opened the kit on (b)(6) 2018 and the results of the calibration are as follows: rfv s1 = 1583/1595 (normal range 1879-3355) second calibration was initiated and still gave an invalid s1 result = 1543/1566 (normal range 1879-3355).The customer reported delayed results for a patient greater than 24 hours due to the invalid calibration because the customer did not have another lot in inventory.The customer reported that the patient's serum was stored while waiting availability of another lot.An internal biomérieux investigation will be initiated.
 
Manufacturer Narrative
An internal investigation was performed for a customer in france reporting invalid calibration and s1 results associated with vidas® fsh (lot 1006080890).Tests performed during the in-house investigation, confirmed a decrease of the s1 signal for multiple lots.Cross-testing between vidas fsh assay strips and the solid phase receptacle (spr) demonstrated that the decrease of signal was related to the strips.The investigation has identified the exact well of the strip leading to the calibration issue.Furthermore, the root cause was linked to multiple lots of a raw material (horse serum) containing specific interfering antibodies.Field safety corrective action (fsca) 3834 was issued on 07mar2018 for vidas fsh lot 1006080890, instructing customers to destroy the impacted lot.A capa (corrective action preventive action) is ongoing to implement corrective and/or preventive actions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® FSH
Type of Device
VIDAS® FSH
Manufacturer (Section D)
BIOMERIEUX SA
376, chemin de l'orme
marcy l'etoile, 69280
FR  69280
MDR Report Key7365694
MDR Text Key103798141
Report Number3002769706-2018-00047
Device Sequence Number1
Product Code CGJ
Combination Product (y/n)N
PMA/PMN Number
C1 EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 06/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/23/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2018
Device Catalogue Number30407
Device Lot Number1006080890
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received06/03/2019
Removal/Correction NumberFSCA 3834
Patient Sequence Number1
-
-